RecruitingNCT05381792

Serial Gut Microbiome and Bacterial Gene Markers Changes After Endoscopic Resection of Colorectal Advanced Neoplasia

A Pilot Study to Assess Serial Gut Microbiome and a Panel of Bacterial Gene Markers (M3) Changes After Endoscopic Resection of Colorectal Advanced Neoplasia


Sponsor

Chinese University of Hong Kong

Enrollment

50 participants

Start Date

Sep 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The investigators hypothesize that gut microbiome composition and the four bacterial gene markers (M3) show dynamic changes after endoscopic resection of advanced neoplasia, some key bacteria are associated with restoration of gut microbiome after endoscopic resection.


Eligibility

Min Age: 18 YearsMax Age: 90 Years

Plain Language Summary

Simplified for easier understanding

This study is tracking changes in gut bacteria (the microbiome) and related gene markers before and after an endoscopic procedure to remove precancerous growths or early-stage cancer from the colon or rectum, to understand how the gut microbiome relates to colorectal disease. **You may be eligible if...** - You are between 18 and 90 years old - You need an endoscopic procedure (such as EMR or ESD) to remove a large polyp or early-stage colorectal cancer - You have given written informed consent **You may NOT be eligible if...** - You have a condition that makes colonoscopy unsafe (e.g., bowel obstruction or perforation) - You have active gastrointestinal bleeding or are on blood thinners that cannot be paused - You are pregnant or breastfeeding - You have severe health problems (ASA Grade 4 or above) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTBacterial gene markers test

Bacterial gene markers test using qPCR


Locations(1)

Prince of Wales Hospital

Shatin, New Territories, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05381792


Related Trials